Graham A. Ross
Impact in
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Cancer Research top 1%
- Breast Cancer Treatment Studies
Papers in
- Oncology 22
- HER2/EGFR in Cancer Research 14
- Lung Cancer Research Studies 8
- Cancer Treatment and Pharmacology 1
-
- Effects of Radiation Exposure 2
- Monoclonal and Polyclonal Antibodies Research 1
- Co-authors
- Javier Cortés (10 shared papers)Sandra M. Swain (8 shared papers)Emma Clark (7 shared papers)Mark C. Benyunes (4 shared papers)Sung‐Bae Kim (3 shared papers)Seock‐Ah Im (5 shared papers)Young‐Hyuck Im (4 shared papers)Tadeusz Pieńkowski (3 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)The Lancet Oncology (3 papers)The Oncologist (2 papers)New England Journal of Medicine (2 papers)Breast Cancer Research (1 paper)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Graham A. Ross
28 papers receiving 10.3k citations
Graham A. Ross's Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 7.7k
- Cancer Research 1.9k
- Radiology, Nuclear Medicine and Imaging 2.2k
- Pulmonary and Respiratory Medicine 2.0k
- Genetics 374
Countries citing papers authored by Graham A. Ross
This map shows the geographic impact of Graham A. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham A. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham A. Ross more than expected).
Fields of papers citing papers by Graham A. Ross
This network shows the impact of papers produced by Graham A. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham A. Ross. The network helps show where Graham A. Ross may publish in the future.
Co-authors
The 25 scholars most cited alongside Graham A. Ross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer Hit paper breakdown → | 2011 | 2024 |
| 2 | Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial Hit paper breakdown → | 2011 | 1862 |
| 3 | Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer Hit paper breakdown → | 2015 | 1669 |
| 4 | Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study Hit paper breakdown → | 2013 | 808 |
| 5 | Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer Hit paper breakdown → | 1999 | 787 |
| 6 | 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial Hit paper breakdown → | 2016 | 675 |
| 7 | 2010 | 507 | |
| 8 | 2006 | 500 | |
| 9 | 2007 | 307 | |
| 10 | 2014 | 298 | |
| 11 | 2012 | 200 | |
| 12 | 2001 | 197 | |
| 13 | 2013 | 133 | |
| 14 | 2006 | 119 | |
| 15 | 2006 | 89 | |
| 16 | 2001 | 79 | |
| 17 | 2014 | 74 | |
| 18 | 2000 | 59 | |
| 19 | 2014 | 55 | |
| 20 | 2014 | 54 |
About Graham A. Ross
Graham A. Ross is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Allergy, Reproductive Medicine and Cancer Research, having authored 28 papers that have together received 10.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (14 papers), Lung Cancer Research Studies (8 papers), Cancer therapeutics and mechanisms (3 papers), Effects of Radiation Exposure (2 papers), Cell Adhesion Molecules Research (1 paper), Ovarian cancer diagnosis and treatment (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Oncology (7.7k citations), Cancer Research (1.9k citations), Radiology, Nuclear Medicine and Imaging (2.2k citations), Pulmonary and Respiratory Medicine (2.0k citations) and Genetics (374 citations). Graham A. Ross has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Javier Cortés, Sandra M. Swain, Emma Clark, Mark C. Benyunes, Sung‐Bae Kim, Seock‐Ah Im, Young‐Hyuck Im, Tadeusz Pieńkowski, José Luiz Pedrini and José Baselga. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology, The Oncologist, New England Journal of Medicine and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.